Circulating lobular breast carcinoma cells
Int J Lab Hematol. 2024 Apr 24. doi: 10.1111/ijlh.14295. Online ahead of print.NO ABSTRACTPMID:38658384 | DOI:10.1111/ijlh.14295 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 24, 2024 Category: Hematology Authors: Brent Tan Jean Oak Source Type: research

Applicability of mono dysplasia score on the new Sysmex XR analyzer range to predict diagnosis of chronic myelomonocytic leukaemia
Int J Lab Hematol. 2024 Apr 23. doi: 10.1111/ijlh.14296. Online ahead of print.NO ABSTRACTPMID:38653571 | DOI:10.1111/ijlh.14296 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 23, 2024 Category: Hematology Authors: Edouard Cornet Sandrine Girard Romain Blottiere Agn ès Leonard Lucile Deloriere C éline Bossard Pauline Kerneves Yohann Repesse Source Type: research

Immune reconstitution in children after haploidentical haematopoietic stem cell transplantation
CONCLUSION: Paediatric patients who undergo haploidentical HSCT with PTCy are likely to have delayed IR and an increased risk of viral reactivation/infection compared with HLA-matched HSCT. The addition of ATG to PTCy delayed T cell recovery and increased risk of BKV reactivation.PMID:38646695 | DOI:10.1111/ijlh.14290 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 22, 2024 Category: Hematology Authors: Saranthorn Apasuthirat Nopporn Apiwattanakul Usanarat Anurathapan Nintita Sripaiboonkij Thokanit Karan Paisooksantivatana Ekawat Pasomsub Suradej Hongeng Samart Pakakasama Source Type: research

Immune reconstitution in children after haploidentical haematopoietic stem cell transplantation
CONCLUSION: Paediatric patients who undergo haploidentical HSCT with PTCy are likely to have delayed IR and an increased risk of viral reactivation/infection compared with HLA-matched HSCT. The addition of ATG to PTCy delayed T cell recovery and increased risk of BKV reactivation.PMID:38646695 | DOI:10.1111/ijlh.14290 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 22, 2024 Category: Hematology Authors: Saranthorn Apasuthirat Nopporn Apiwattanakul Usanarat Anurathapan Nintita Sripaiboonkij Thokanit Karan Paisooksantivatana Ekawat Pasomsub Suradej Hongeng Samart Pakakasama Source Type: research

New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests
CONCLUSIONS: ALD50 and WaS showed acceptable sensitivity and specificity to LA and progressive coagulation factor inhibitor, respectively. These indexes would be useful for the differentiation between LA, factor deficiency, and progressive coagulation factor inhibitor in the mixing tests.PMID:38644054 | DOI:10.1111/ijlh.14289 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 21, 2024 Category: Hematology Authors: Daiki Shimomura Osamu Kumano Kaori Ueda Keisuke Kitano Nobuo Arai Masashi Shimada Mikio Kamioka Source Type: research

Acidosis can temporarily and markedly prolong APTT
Int J Lab Hematol. 2024 Apr 21. doi: 10.1111/ijlh.14293. Online ahead of print.NO ABSTRACTPMID:38644055 | DOI:10.1111/ijlh.14293 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 21, 2024 Category: Hematology Authors: Anne M Sermon-Cadd Lee J Beckett Steve Kitchen Source Type: research

Oligomonocytic chronic myelomonocytic leukemia is eligible to MDS-score and not Mono-dysplasia score
Int J Lab Hematol. 2024 Apr 21. doi: 10.1111/ijlh.14294. Online ahead of print.NO ABSTRACTPMID:38644333 | DOI:10.1111/ijlh.14294 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 21, 2024 Category: Hematology Authors: Benjamin Podvin Marion Magierowicz Val érie Soenen Florent Dumezy Nicolas Duployez Agn ès Charpentier Source Type: research

Performance of direct oral anticoagulant (DOAC) testing by hemostasis laboratories: The Australasian/Asia-Pacific experience
CONCLUSION: We hope our findings, reflecting on mostly consistent reporting of DOAC levels and interpretation provides reassurance for clinicians requesting these measurements, and helps support their implementation in regions where there is a paucity of test availability.PMID:38644463 | DOI:10.1111/ijlh.14288 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 21, 2024 Category: Hematology Authors: Emmanuel J Favaloro Sandya Arunachalam Elysse Dean Source Type: research

Responsible use of chatbots to advance the laboratory hematology scientific literature: Challenges and opportunities
Int J Lab Hematol. 2024 Apr 19. doi: 10.1111/ijlh.14285. Online ahead of print.NO ABSTRACTPMID:38639069 | DOI:10.1111/ijlh.14285 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 19, 2024 Category: Hematology Authors: Fabienne Lucas Ian Mackie Giuseppe d'Onofrio John L Frater Source Type: research

Obinutuzumab interference with immunoelectrophoresis in a case of follicular lymphoma
Int J Lab Hematol. 2024 Apr 16. doi: 10.1111/ijlh.14284. Online ahead of print.NO ABSTRACTPMID:38627894 | DOI:10.1111/ijlh.14284 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 17, 2024 Category: Hematology Authors: Unal Atas Volkan Karakus Imge Bortay Tekin Ozgur Aydin Omur Gokmen Sevindik Levent Undar Source Type: research

Obinutuzumab interference with immunoelectrophoresis in a case of follicular lymphoma
Int J Lab Hematol. 2024 Apr 16. doi: 10.1111/ijlh.14284. Online ahead of print.NO ABSTRACTPMID:38627894 | DOI:10.1111/ijlh.14284 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 17, 2024 Category: Hematology Authors: Unal Atas Volkan Karakus Imge Bortay Tekin Ozgur Aydin Omur Gokmen Sevindik Levent Undar Source Type: research

Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy
Int J Lab Hematol. 2024 Apr 15. doi: 10.1111/ijlh.14281. Online ahead of print.ABSTRACTComplement inhibitors are the mainstay of paroxysmal nocturnal hemoglobinuria (PNH) treatment. The anti-C5 monoclonal antibody eculizumab was the first treatment to improve hemolysis, thrombotic risk, and survival in PNH although at the price of a life-long intravenous fortnightly drug. Additionally, suboptimal response may occur in up to 2/3 of patients with persistent anemia due to incomplete control of intravascular hemolysis, development of upstream C3-mediated extravascular hemolysis (EVH), or concomitant bone marrow failure. Ravuli...
Source: International Journal of Laboratory Hematology - April 16, 2024 Category: Hematology Authors: Francesco Versino Bruno Fattizzo Source Type: research

Developments in the International Journal of Laboratory Hematology
Int J Lab Hematol. 2024 Apr 16. doi: 10.1111/ijlh.14287. Online ahead of print.NO ABSTRACTPMID:38623848 | DOI:10.1111/ijlh.14287 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 16, 2024 Category: Hematology Authors: Ian Mackie Giuseppe D'Onofrio Source Type: research

Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy
Int J Lab Hematol. 2024 Apr 15. doi: 10.1111/ijlh.14281. Online ahead of print.ABSTRACTComplement inhibitors are the mainstay of paroxysmal nocturnal hemoglobinuria (PNH) treatment. The anti-C5 monoclonal antibody eculizumab was the first treatment to improve hemolysis, thrombotic risk, and survival in PNH although at the price of a life-long intravenous fortnightly drug. Additionally, suboptimal response may occur in up to 2/3 of patients with persistent anemia due to incomplete control of intravascular hemolysis, development of upstream C3-mediated extravascular hemolysis (EVH), or concomitant bone marrow failure. Ravuli...
Source: International Journal of Laboratory Hematology - April 16, 2024 Category: Hematology Authors: Francesco Versino Bruno Fattizzo Source Type: research

Developments in the International Journal of Laboratory Hematology
Int J Lab Hematol. 2024 Apr 16. doi: 10.1111/ijlh.14287. Online ahead of print.NO ABSTRACTPMID:38623848 | DOI:10.1111/ijlh.14287 (Source: International Journal of Laboratory Hematology)
Source: International Journal of Laboratory Hematology - April 16, 2024 Category: Hematology Authors: Ian Mackie Giuseppe D'Onofrio Source Type: research